|

 

Microsoft word - document3

VERBENACEAE
The Verbenaceae consists of herbs, shrubs or trees, with square stems and opposite or rarely alternate leaves. The flowers are similar to those of the Lamiaceae except that the ovary is entire, with the style proceeding from the top, and the flowers are in racemes or cymes rather than in verticils. The fruit is dry or succulent usually shorter than the persistent calyx, 2- or 4-celled with one seed in each cell. Vitex agnus-castus and Verbena officinalis are medicinal plants of the Verbenaceae. Verbena officinalis
Family Verbenaceae Description
An annual or short-lived erect perennial, nearly glabrous, with square stemmed, spreading, wiry branches which may grow to 80 cm tall. Basal
leaves stalked, obovate or oblong, dark green and deeply toothed, upper
leaves opposite, few, often sessile and lanceolate. Flowers very small, pale
blue, in long, slender spikes, the lower ones becoming distant as the spike
lengthens, each one sessile in the axil of a small bract. Flowers from
summer to autumn.
Habitat and cultivation
Native to Europe, North Africa and West Asia, in damp, sunny situations and widely naturalised. Grows from seed and is better shown
fresh each year. Old plants become straggly and less productive. Drought
tender, frost resistant.
Parts used
The herb gathered at, or just prior to, flowering. In Germany the roots are also used1.
Active constituents
1) Iridoids - mainly verbenalin (cornin) around 0.1-0.3% highest during flowering and in mature plants2,3,4,5,6,7. Also hastatoside and aucubin 2) Phenylpropanoids (up to 5%) including verbascoside and its isomer eukovoside and their derivatives2,5,6 3) Flavonoids including those based on luteolin, apigenin, kaempferol, quercetin, diosmetin and wogonin2,3,5,6,8,9 4) Volatile oil including citral, limolene, cineol and β-myrcene10 Also contains mucilage, tannins, sterols including daucosterol11 and β-sitosterol12, triterpenes including ursolic and oleanolic acids13,14 and fatty acids15.
Nutritional constituents
C16 and β-carotene17 Rich in minerals especially calcium and magnesium, also sodium, potassium, iron, copper, zinc and manganese18
Actions
1) Nervine 2) Thymoleptic 3) Diaphoretic 4) Sedative 5) Spasmolytic Also reputedly a galactagogue. Scientific information
Verbena is a medicinal herb that enjoyed a great reputation in the past, being used for a wide range of health conditions19. Although the active constituents have been investigated in recent times the pharmacological activity has not and the herb appears to have lost some of its former esteem. Verbena has been part of the medical tradition of both the East and the West. In Spain the herb has been used as a topical anti-inflammatory20, in Sicily as a treatment for psoriasis21, in Morocco for hypertension22 and in China for malaria. In vitro - Studies that have been conducted indicate:- • the essential oil has good anti-oxidant activity23 • the herb can moderately inhibit COX-1 activity24. (Animal studies indicate the herb and/or isolated constituents have anti-inflammatory activity12,20 and that the herb has potential as a neuroprotective agent for example against Alzheimer's disease25.) • the flavonoids have antibacterial activity against Staphylococcus aureus, Bacillus subtilis and Escherichia coli26 • the herb has strong oestrogen and progesterone-receptor binding capacity27 (an early study had shown it to be androgenic1) • citral, at concentrations equivalent to that found in infusions, is apoptotic in several haemopoietic cancer cell lines28 In vivo - An epidemiological study found that drinking herbal teas, Verbena being one commonly consumed, was inversely related to the incidence of breast cancer possibly due to the polyphenol
(flavonoids and phenylpropanoids) and/or essential oil content29.
Medicinal uses
Cardiovascular System
• fevers (in early stages) • colds • influenza Gastro-intestinal Tract • cholecystalgia • jaundice • depression • melancholia • epilepsy • migraine • hysteria • convalescence Reproductive Tract • increase lactation Pharmacy
Three times daily Infusion Tincture 1:5 (40%) Fluid Extract (25%) Precautions and/or Safety
Verbena infusions inhibited iron absorption in an in vitro model30 and an in vivo test with a single food source has estimated inhibition of iron up-take to be around 59%31. Iron absorption is inhibited by polyphenols but the effect is less than occurs with black tea. The actual inhibition may be altered when taken with complex meals, as occurs in real life. There is a report of contact dermatitis to the herb32. Historical uses
Abscesses; tumours; sores/wounds - styptic and vulnerary; as an antidote to poisons, haemorrhoids; facial neuralgia; calculus; "cold complaints of the womb", infertility; aphrodisiac; headaches (poultice); rheumatism (external); worms; the plague; mouth ulcers, acute dysentery, enteritis. As a wash for freckles and morphews; to clear eyesight and strengthen it. Vitex agnus-castus
Chaste tree, agnus-castus Family Verbenaceae Description
An aromatic, deciduous shrub or small tree, growing 1-4 x 2 m high with branches that divide frequently at the top. Branches are felted with dense
white hairs. Leaves are long-stalked, palmate with 5-7 lance-shaped
leaflets, green above and felted beneath. Flowers grow in long, terminal,
interrupted spikes and are small and usually lavender coloured, rarely
rose-pink. Corolla 6-9 mm, almost two-lipped, hairy outside. Stamens
longer and projecting. Calyx hairy. Fruits fleshy and reddish black.
Flowers mid to late summer.
Habitat and cultivation
Native to Southern Europe and Western Asia growing in moist, well- drained soil in sheltered, sunny places. Grown from stratified seed or
cuttings. Frost resistant, drought tender.
Parts used
The berries harvested when ripe in autumn. Active constituents
1) Iridoid glycosides including agnuside, aucubin and eurostoside33 2) Flavonoids - mainly the tetramethoxyflavone, casticin, also orientin, eupatorin, apigenin, luteolin and penduletin34,35,36 3) Essential oil a) monoterpenes - sabinene, 1,8-cineole, β-caryophyllene and farnesene37 b) diterpenes including those of labdane type - vitexlactam, rotundifuran, vitetrifolin B, C and D - and clerodane type38,39,40,41 c) sesquiterpenes - spathulenol35 Also contains fatty acids including linoleic acid42. Nutritional constituents
1) Hormone regulator 2) Galactagogue Vitex has been documented as having emmenagogue, vulnerary, carminative, anthelmintic and anti- inflammatory properties but scientific corroboration of these is lacking.
Scientific information
Various parts of chaste tree have been used medicinally for thousands of years. The fruits in particular, besides being used as a food spice by the monks (hence the name monk's pepper), were believed to ensure celibacy and chastity which would have been an added advantage to them. Unlike Verbena the reputation of this herb seems to have grown in recent times making it one of the most commonly used herbs employed for hormonal imbalance. Its primary use today, for menstrual disorders, was however known from ancient Greek times43. There have been a number of studies into its action over the last fifty years and clinical efficacy has resulted in German Commission E approving the herb for premenstrual syndrome (PMS), mastalgia
and irregular menstruation.
Hormonal
In vitro - The chemistry and pharmacology of Vitex is complex but mechanisms thought to contribute to its action include:- • interaction at dopamine D2-receptors in the anterior pituitary gland which reduces prolactin levels, is due at least in part to the diterpenes, and is presumed to be the mechanism by which the herb helps with breast discomfort, referred to as mastalgia or mastodynia38,44,45. Dopamine agonists have been found empirically to reduce breast pain and heaviness and mood disturbances associated with PMS. (Prolactin is elevated in 70% of women who suffer breast discomfort pre-menstrually50) • interaction with oestrogen receptor (ER) sites46 - the action appears complex. The whole extract had no binding affinity for ERα47 although its constituent linoleic acid bound to both ERα and ERβ sites42. On the other hand the flavonoids, apigenin and penduletin, have affinity for ERβ receptors - these receptors are involved in fat tissue regulation, prevention of malignant proliferation and may counter ERα activity38,48 • may interact at cholinergic receptor sites49 • interaction/agonist activity at µ-opiate and possibly other opiate receptor sites45. The µ-opiate receptor is mainly activated by β-endorphin, an endogenous peptide, which helps regulate the menstrual cycle via the hypothalamic-pituitary-adrenal (HPA) axis. The opiate system is also involved in pain perception, mood and appetite regulation and the level of β-endorphin is inversely proportional to the severity of PMS symptoms like abdominal discomfort, anxiety and food cravings49. In vivo - At least 30% of women are considered to experience pre-menstrual problems and according to one set of criteria for about 2.5-3.0% of all women of reproductive age symptoms are severe whilst in 40% they are moderate. The aetiology of PMS symptoms is proposed to be due to one or several of the following factors50:- • low progesterone levels in the luteal phase • disturbance of aldosterone activity (fluid retention) • imbalance in HPA axis activity with reduced adrenal hormones • disturbances in neurotransmitters • prostaglandin deficiency • raised levels of prolactin • nutritional factors e.g. low calcium and magnesium levels, vitamin deficiencies, food intolerance • stress Clinical trials into the effects of Vitex for hormonally-related problems have so far shown benefit • moderate to severe PMS51 • the majority of symptoms associated with PMS including psychological (anger, irritability, mood alteration, negative feelings) and physical (bloating, headache, breast fullness, pain, fluid retention)52,53,54,55 • PMDD - Premenstrual dysphoric disorder - effects comparable to fluoxetine, the SSRI being specifically better for psychological symptoms and Vitex for physical ones56 • cyclical mastalgia54,57,58 - prolactin level reduction comparable to bromocriptine • luteal phase defects due to latent hyperprolactinaemia - it reduced prolactin level, normalised length of the luteal phase and progesterone production57,59 • pathologically raised prolactin levels57 • infertility - due to secondary amenorrhoea or luteal insufficiency60 - Vitex raised progesterone levels, lengthened duration of raised basal temperature in the luteal-phase and normalised the length of both long and short cycles61 • menopausal hot flushes and night sweats - Vitex was one herb in a combination. There were no adverse changes to hormone levels, vaginal tissues or liver function62 A number of clinical trials conducted some decades ago reported that Vitex benefited acne vulgaris63,64, premenstrual fluid retention65, amenorrhoea66 and increased lactation67. There are also anecdotal reports of the herb reducing prolactin levels caused by pituitary micro-adenomas68,69. Based on measurements in healthy men it seems that the dose of Vitex used can vary the response of prolactin secretion (biphasic) - levels were increased slightly at low doses of Vitex but decreased
slightly at higher doses70. Furthemore these changes were larger the higher the base level of prolactin
prior to dosing70.
Other
In vitro - Both water and ethanol extracts of Vitex are significantly anti-oxidant, the flavonoids were not considered to be wholly responsible for this activity35,71. Extracts have antitumour and antiproliferative activity in a number of fast growing or cancer cell lines including gastric72, prostate73, breast74, ovary75, colon75 and lung75. This action does not seem to be specific for cancer cells however75, affecting other relatively fast growing cell lines and indicating a potential use of the herb in the treatment of benign prostatic hyperplasia73. In vivo - Melatonin levels were increased in healthy men in a dose-dependent manner by Vitex although the actual circadian rhythm of secretion was unaffected76. Sprays made from the berries had good insecticide properties against fleas, mosquitoes, flies and ticks77.
Medicinal uses
Reproductive Tract
Vitex is used almost exclusively in women as a hormone balancer for: • amenorrhoea, secondary • metrorrhagia • oligomenorrhoea • infertility • menopausal symptoms • menorrhagia • polymenorrhoea • cyclical mastalgia • premenstrual syndrome • to help regulate menstrual cycle on cessation of contraceptive pill Its indications include any condition that subsided in pregnancy and returned at the cessation of breast feeding or any premenstrual aggravation. Skin • acne (70% improvement in 3 months) This effect may be due to an anti-androgenic action. It is useful for teenage acne in both sexes. Pharmacy
Three times daily Decoction The daily dose that follows may be effectively taken as a single dose before breakfast Tincture 1:5 (25%) 1 - 3 ml (20-60 drops) Alternatively the weekly dose may be given in equal doses, three times a day. Vitex used in the above trials were standardised on casticin and represented the equivalent of 120- 480 mg of herb daily. The study on prolactin changes in men used a low dose of 120 mg and high dose
of 480 mg.
Precautions and/or Safety
All the above clinical trials report good tolerance to the herb. Although most trials on PMS measured improvements after 3 cycles, these can be expected to occur sooner than that. In the one study that used a 3 cycle treatment protocol with follow-up carried out 3 cycles after cessation of Vitex, symptoms had returned to around 22% below where they were before Vitex was used53. In spite of the herb's ability to reduce prolactin levels it is not contra-indicated in lactation and in fact studies have supported its use for improving milk flow, a process governed by prolactin. The biphasic response to Vitex may explain this anomaly or it may be due to mechanism(s) not yet understood. Side-effects that have been reported include nausea, headache, itching, erythema, gastro-intestinal disturbances, depression, fatigue, breast pain, menstrual disorders and acne51,78. They are however infrequent, mild and reversible. Large doses should be avoided although no toxicity due to overdose has been reported. There is one report of mild ovarian hyperstimulation syndrome attributed to the use of Vitex in a woman undergoing unstimulated in-vitro fertilisation treatment79 and one of arteriospasm78.
Interactions
No interactions have been reported in the extensive testing that has been done to-date although a theoretical interaction has been suggested between Vitex and dopaminergic antagonists78. Some of the clinical trials on PMS included women using contraceptive pills (unspecified type) as the latter do not always improve these symptoms. No interactions have been reported from using the
two concomitantly52,53.
Historical uses
To curb sexual desire; inflammation, injuries; animal bites, an enlarged spleen; inflamed uterus. Paralysis; pains in the limbs; weakness. 1 Stainton RE. Br J Phytother. 1990;1(3-4):43-46 2 Bilia AR et al. J Pharm Biomed Anal. 2008 Feb 13;46(3):463-70 3 Tian J et al. Zhongguo Zhong Yao Za Zhi. 2005 Feb;30(4):268-9 4 Rosendal S et al. Phytochemistry. 1989 Jan;28(1):97-105 5 Muller A et al. Chromatographia. 2004 Aug;60(3-4):193-7 6 Calvo MI et al. Chromatographia. 1997 Sep;46(5):241-4 7 Horodysky GR et al. J Biol Chem. 1969 Jun 25;244(12):3110-6 8 Chen GM et al. Zhong Yao Cai. 2006 Jul;29(7):677-9 9 Kawashty SA, El-Garf IA. Biochem Syst Ecol. 2000 Nov 1;28(9):919-21 10 De-Oliveira AC et al. Toxicol. 1997 Dec 26;124(2):135-40 11 Zhang T et al. Zhongguo Zhong Yao Za Zhi. 2000 Nov;25(11):676-8 12 Deepak M, Handa SS. Phytother Res. 2000 Sep;14(6):463-5 13 Liu CH, Liu Y. Zhongguo Zhong Yao Za Zhi. 2002 Dec;27(12):916-8 14 Deepak M, Handa SS. Phytochemistry. 1998 Sep;49(1):269-71 15 Guil JL et al. J Chromatogr A. 1996 Jan;719(1):229-35 16 Jones E, Hughes RE. Phytochemistry. 1983 Jan;22(11):2493-9 17 Winde E et al. Arch Pharm. 1961 Apr;294/66:220-9 18 Guil Guerrero JL et al. J Food Comp Anal. 1998 Dec;11(4):322-8 19 Guarrera PM et al. J Ethnopharmacol. 2005 Jan 15;96(3):429-44 20 Calvo MI. J Ethnopharmacol. 2006 Oct 11;107(3):380-2 21 Amenta R et al. Fitoterapia. 2000 Aug;71(Suppl 1):513-20 22 Eddouks M et al. J Ethnopharmacol. 2002 Oct;82(2):97-103 23 Mantle D et al. Comp Biochem Physiol. 1998 Dec;121(4):385-91 24 Li RW et al. J Ethnopharmacol. 2003 Mar;85(1):25-32 25 Lai SW et al. Neuropharmacol. 2006 May;50(6):641-50 26 Hernandez NE et al. J Ethnopharmacol. 2000 Nov;73(1-2):317-22 27 Zava DT et al. Proc Soc Exp Biol Med. 1998 Mar;217(3):369-78 28 Dudai N et al. Planta Med. 2005 May;71(5):484-8 29 Hiroven T et al. Ann Epidemiol. 2006 Jul;16(7):503-8 30 Zaida F et al. Ann Nutr Metab. 2006;50(3):237-41 31 Hurrell RF et al. Br J Nutr. 1999 Apr;81(4):289-95 32 Del Pozo MD et al. Contact Dermatitis. 1994 Sep;31(3):200-1 33 Kuruuzum-Uz A et al. Phytochemistry. 2003 Aug;63(8):959-64 34 Asker E et al. Acta Crystallog Sec E. 2006 Sep;62(9):4159-61 35 Hajdu Z et al. Phytother Res. 2007 Apr;21(4):391-4 36 Hirobe C et al. Phytochemistry. 1997 Oct;46(3):521-4 37 Sorensen JM, Katsiotis ST. Planta Med. 2000 Apr;66(3):245-50 38 Jarry H et al. Maturitas. 2006 Nov 1;55(Suppl 1):S26-36 39 Li S et al. Tetrahed Lett. 2002 Jul;43(29):5131-4 40 Hoberg E et al. Planta Med. 2000 May;66(4):352-5 41 Hoberg E et al. Phytochemistry. 2003 Jun;63(3):375 42 Liu J et al. Phytomedicine. 2004 Jan;11(1):18-23 43 Tsoulogiannis IN, Spandidos DA. Hormones (Athens). 2007 Jan-Mar;6(1):80-2. 44 Wuttke W et al. Phytomedicine. 2003 May;10(4):348-57 45 Meier B et al. Phytomedicine. 2000 Oct;7(5):373-81 46 Liu J et al. J Agric Food Chem. 2001 May;49(5):2472-9 47 Oerter Klein K et al. J Clin Endocrinol Metab. 2003 Sep;88(9):4077-9 48 Jarry H et al. Planta Med. 2003 Oct;69(10):945-7 49 Webster DE et al. J Ethnopharmacol. 2006 Jun 30;106(2):216-21 50 Milewicz A, Jedrzejuk D. Maturitas. 2006 Nov;55 (Suppl 1):S47-54 51 Prilepskaya VN et al. Maturitas. 2006 Nov;55 (Suppl 1):S55-63 52 Schellenberg R. BMJ. 2001 Jan 20;322(7279):134-7 53 Berger D et al. Arch Gynecol Obstet. 2000 Nov;264(3):150-3 54 Loch EG et al. J Womens Health Gend Based Med. 2000 Apr;9(3):315-20 55 Lauritzen C et al. Phytomedicine. 1997;4:183-9 56 Atmaca M et al. Hum Psychopharmacol. 2003 Apr;18(3):191-5 57 Halaska M et al. Breast. 1999 Aug;8(4):175-81 58 Halaska M et al. Ceska Gynekol. 1998 Oct;63(5):388-92
59 Milewicz A et al. Arzneimittelforschung. 1993 Jul;43(7):752-6
60 Gerhard II et al. Forsch Komplementarmed. 1998;5(6):272-8
61 Westphal LM et al. Clin Exp Obstet Gynecol. 2006;33(4):205-8
62 Rotem C, Kaplan B. Gynecol Endocrinol. 2007 Feb;23(2):117-22
63 Amman W. Ther Ggw. 1967 Jan;106(1):124-6
64 Amman W. Z Allgemeinmed. 1975 Dec 20;51(35):1645-8
65 Amman W. ZFA (Stuttgart). 1979 Jan 10;55(1):48-51
66 Amman W. ZFA (Stuttgart). 1982 Feb 10;58(4):228-31
67 Bautze HJ. Medizinische. 1953 Feb 7;21(6):189-90.
68 Gallagher J et al. Eur J Obstet Gynecol Reprod Biol. 2008 Apr;137(2):257-8
69 Tamagno G et al. Eur J Obstet Gynecol Reprod Biol. 2007 Nov;135(1):139-40
70 Merz PG et al. Exp Clin Endocrinol Diabetes. 1996;104(6):447-53
71 Saglam H et al. Phytother Res. 2007 Nov;21(11):1059-60
72 Ohyama K et al. Int J Biochem Cell Biol. 2005 Jul;37(7):1496-510
73 Weisskopf M et al. Planta Med. 2005 Oct;71(10):910-6
74 Dixon-Shanies D, Shaikh N. Oncol Rep. 1999 Nov-Dec;6(6):1383-7
75 Ohyama K et al. Biol Pharm Bull. 2003 Jan;26(1):10-18
76 Dericks-Tan JS et al. Exp Clin Endocrinol Diabetes. 2003 Feb;111(1):44-6
77 Mehlhorn H et al. Parasitol Res. 2005 Mar;95(5):363-5
78 Daniele C et al. Drug Saf. 2005;28(4):319-32
79 Cahill DJ et al. Hum Reprod. 1994 Aug;9(8):1469-70
Violaceae

Source: http://www.thymeheal.co.nz/assets/Web-sample.pdf